M&A / Deals Boehringer signs AI drug discovery deal with Owkin PharmaphorumBoehringer Ingelheim has joined Sanofi and AstraZeneca in signing up to deploy Owkin's AI platform K Pro in its drug discovery operations.Read full story pharminent September 3, 2026 (Last updated: September 3, 2026) Pharmaphorum Boehringer Ingelheim has joined Sanofi and AstraZeneca in signing up to deploy Owkin’s AI platform K Pro in its drug discovery operations. Read full story Post navigation Previous: Novartis signs $3.2bn drug delivery deal with AlteogenNext: Ivonescimab Beats Keytruda on Survival in China-Only Trial as Its Global Study Stumbles Related Stories M&A / Deals Novartis signs $3.2bn drug delivery deal with Alteogen pharminent September 3, 2026 M&A / Deals Ono Pharmaceutical joins forces with Aitia for drug discovery in neurology pharminent September 2, 2026 M&A / Deals Lilly adds to immune drug pipeline with $2.9B Merida buyout pharminent August 31, 2026